Rhythm Pharmaceuticals, Inc. Share Price

Rhythm Pharmaceuticals, Inc. Share Price

NASDAQ: RYTM | Mid Cap
$93.22
+$1.18 (1.28%) Last updated on 29 Oct, 2026 | 20:38 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Rhythm Pharmaceuticals, Inc. Stock Performance

Open
$93.94
Prev. Close
$92.04
Circuit Range
N/A
Day Range
$93.05 - $93.94
Year Range
$74.51 - $122.00
Volume
9,580
Average Traded
$93.51

Rhythm Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Rhythm Pharmaceuticals, Inc.'s share price is $93.22. The stock opened at $93.94, compared to its previous close of $92.04. During today's trading session, Rhythm Pharmaceuticals, Inc.'s share price traded between $93.05 and $93.94, with an average price of $93.50. Over the past 52 weeks, the stock has recorded a high of $122.00 and a low of $74.51. In terms of performance, Rhythm Pharmaceuticals, Inc.'s share price has risen by 14.45% over the last six months and is down 18.19% on a year-on-year basis.

Rhythm Pharmaceuticals, Inc. Share Price Chart

Line chart of the Rhythm Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 93.05 to 94.23, ending at 93.22.
$93.05$93.94
L
Show Current Price
H

Rhythm Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$6.06B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.05
Revenue (TTM)
$189.76B
Return On Equity (TTM)
-204.13%
Profit Margin
-106.41%
Debt to Equity
1.03
Quarterly Earnings Growth YoY
7.22%

Rhythm Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$51.30$57.25$60.11$71.26
Net Profit-$54.28-$48.84-$56.74-$50.36
Net Profit Margin-105.81%-85.31%-94.39%-70.67%
Income ChangeN/A10.02%-16.18%11.24%

Rhythm Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$23.64$77.43$130.13$189.76
Net Profit-$181.12-$184.68-$264.57-$201.92
Net Profit Margin-766.16%-238.51%-203.31%-106.41%
Income ChangeN/A-1.97%-43.26%23.68%

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Rhythm Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$95.83
$93.47
-2.05%
Sep 2026
$106.20
$95.42
-15.31%
Aug 2026
$100.39
$112.67
+13.50%
Jul 2026
$113.03
$99.27
-10.52%
Jun 2026
$87.60
$110.93
+25.54%
May 2026
$81.28
$88.36
+8.48%
Apr 2026
$88.03
$81.45
-6.38%
Mar 2026
$90.18
$87.00
-6.28%
Feb 2026
$105.28
$92.83
-9.46%
Jan 2026
$107.08
$102.53
-4.29%
Dec 2025
$107.91
$107.13
-1.81%
Nov 2025
$113.88
$109.11
-4.24%

RYTM Share Price FAQs